Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1332)
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
8,000
Price
$35.10
Total Value
$280.80K
Shares Held After
103,412
% of Holdings
7.2%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
46,776
Price
$45.00
Total Value
$2.10M
Shares Held After
6,555,102
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
787,024
Price
$45.38
Total Value
$35.72M
Shares Held After
6,601,878
% of Holdings
10.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
1,477
Price
$45.00
Total Value
$66.47K
Shares Held After
219,405
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
24,846
Price
$45.38
Total Value
$1.13M
Shares Held After
220,882
% of Holdings
10.1%
Faeth Therapeutics, Inc. (FTH)
Parikh Anand Kiran — Director
Shares
2,806
Price
$19.76
Total Value
$55.45K
Shares Held After
764,234
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
356
Price
$23.95
Total Value
$8.53K
Shares Held After
8,183
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,329
Price
$23.28
Total Value
$77.50K
Shares Held After
7,827
% of Holdings
42.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,583
Price
$22.40
Total Value
$35.46K
Shares Held After
4,498
% of Holdings
35.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,118
Price
$20.82
Total Value
$23.28K
Shares Held After
2,915
% of Holdings
38.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,797
Price
$20.23
Total Value
$36.35K
Shares Held After
1,797
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
70,200
Price
$0.92
Total Value
$64.58K
Shares Held After
127,338
% of Holdings
55.1%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
9,236
Price
$27.03
Total Value
$249.66K
Shares Held After
913,004
% of Holdings
1.0%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
2,808
Price
$68.00
Total Value
$190.94K
Shares Held After
11,455
% of Holdings
19.7%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
5,120,480
Price
$0.02
Total Value
$92.17K
Shares Held After
0
% of Holdings
100.0%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
9,167
Price
$3.55
Total Value
$32.54K
Shares Held After
119,422
% of Holdings
7.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,619
Price
$81.21
Total Value
$943.58K
Shares Held After
60,137
% of Holdings
16.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
12,130
Price
$80.61
Total Value
$977.80K
Shares Held After
71,756
% of Holdings
14.5%
Verastem, Inc. (VSTM)
Calkins Daniel — Chief Financial Officer
Shares
57
Price
$4.13
Total Value
$235.41
Shares Held After
117,238
% of Holdings
0.0%
Verastem, Inc. (VSTM)
Calkins Daniel — Chief Financial Officer
Shares
4,032
Price
$4.18
Total Value
$16.85K
Shares Held After
117,295
% of Holdings
3.3%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
20,871
Price
$4.18
Total Value
$87.24K
Shares Held After
591,242
% of Holdings
3.4%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
51,560
Price
$16.97
Total Value
$874.97K
Shares Held After
177,461
% of Holdings
22.5%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
61,563
Price
$16.97
Total Value
$1.04M
Shares Held After
177,461
% of Holdings
25.8%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
56,323
Price
$16.97
Total Value
$955.80K
Shares Held After
177,461
% of Holdings
24.1%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$17.01
Total Value
$301.37K
Shares Held After
177,461
% of Holdings
9.1%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
1,806
Price
$95.82
Total Value
$173.05K
Shares Held After
37,648
% of Holdings
4.6%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
300
Price
$30.73
Total Value
$9.22K
Shares Held After
24,353
% of Holdings
1.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
39,700
Price
$30.20
Total Value
$1.20M
Shares Held After
24,653
% of Holdings
61.7%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
190,676
Price
$20.57
Total Value
$3.92M
Shares Held After
3,921,542
% of Holdings
4.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
30,500
Price
$76.18
Total Value
$2.32M
Shares Held After
880,073
% of Holdings
3.3%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
69,500
Price
$75.54
Total Value
$5.25M
Shares Held After
910,573
% of Holdings
7.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
TETRAULT LYNN A. — Director
Shares
37,000
Price
$100.32
Total Value
$3.71M
Shares Held After
7,000
% of Holdings
84.1%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
2,040
Price
$26.00
Total Value
$53.04K
Shares Held After
25,930
% of Holdings
7.3%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,953
Price
$26.00
Total Value
$50.78K
Shares Held After
342,944
% of Holdings
0.6%
Zai Lab Ltd (ZLAB)
Lis William — Director
Shares
7,040
Price
$18.09
Total Value
$127.35K
Shares Held After
50,437
% of Holdings
12.2%
RIGEL PHARMACEUTICALS INC (RIGL)
Ali-Jackson Kamil — Director
Shares
2,500
Price
$35.00
Total Value
$87.50K
Shares Held After
10,125
% of Holdings
19.8%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
93,456
Price
$16.94
Total Value
$1.58M
Shares Held After
418,557
% of Holdings
18.3%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$35.01
Total Value
$350.10K
Shares Held After
129,763
% of Holdings
7.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
271
Price
$539.90
Total Value
$146.31K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,671
Price
$539.18
Total Value
$1.44M
Shares Held After
40,784
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,198
Price
$538.29
Total Value
$1.72M
Shares Held After
43,455
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.13
Total Value
$537.13K
Shares Held After
46,653
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$536.02
Total Value
$607.31K
Shares Held After
47,653
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
995
Price
$534.94
Total Value
$532.27K
Shares Held After
48,786
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
232
Price
$534.09
Total Value
$123.91K
Shares Held After
49,781
% of Holdings
0.5%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
114,746
Price
$10.47
Total Value
$1.20M
Shares Held After
942,485
% of Holdings
10.9%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
34,557
Price
$12.68
Total Value
$438.30K
Shares Held After
80,235
% of Holdings
30.1%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
20,000
Price
$100.00
Total Value
$2.00M
Shares Held After
68,606
% of Holdings
22.6%
CRESCENT BIOPHARMA, INC. (CBIO)
Scalzo Richard William — Chief Financial Officer
Shares
1,112
Price
$17.99
Total Value
$20.00K
Shares Held After
20,298
% of Holdings
5.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Bispham Barbara Harlin — General Counsel and Corporate Secretary.
Shares
1,218
Price
$17.99
Total Value
$21.91K
Shares Held After
19,330
% of Holdings
5.9%
Showing 901–950 of 1332 transactions (page 19 of 27)